No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
CERE Cerevel Therapeutics Holdings
- 42.355
- +0.285+0.68%
Trading Apr 26 11:34 ET
7.69BMarket Cap-15863P/E (TTM)
42.430High41.940Low289.90KVolume42.020Open42.070Pre Close12.26MTurnover0.38%Turnover RatioLossP/E (Static)181.58MShares43.59052wk High11.41P/B3.27BFloat Cap19.59052wk Low--Dividend TTM77.23MShs Float46.161Historical High--Div YieldTTM1.17%Amplitude9.000Historical Low42.293Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Cerevel (CERE.US), acquired by ABBV.US (ABBV.US), achieves key targets for advanced Parkinson's disease drugs
Cerevel Therapeutics announced Thursday that its once-a-day oral drug candidate for Parkinson's disease, tavapadon, has achieved key goals in a key phase 3 trial as a combination therapy.
Sector Update: Health Care Stocks Mixed Pre-Bell Thursday
Health care stocks were mixed pre-bell Thursday, with the iShares Biotechnology ETF (IBB) down 0.1% and the Health Care Select Sector SPDR Fund (XLV) 0.4% higher. Elevance Health (ELV) stock was up mo
AbbVie Buyout Cerevel Posts Late-stage Win for Parkinson's Disease Drug
Express News | Cerevel Therapeutics' Topline Results From Phase 3 TEMPO-3 Trial For Tavapadon For Parkinson's Disease, Met Primary Endpoint, Demonstrating Statistically Significant Increase In Total "On" Time Without Troublesome Dyskinesia Vs. Placebo
Express News | Cerevel Therapeutics Holdings Inc - Tavapadon Was Generally Well Tolerated
Express News | Cerevel: Statistically Significant Reduction in "off" Time, Key Secondary Endpoint, Observed for Tavapadon Treatment Arm
Comments
Analysts believe AbbVie's early acquisition of Cerevel, despite high risks, could potentially yield high returns and avoid bidding wars if emraclidine's data is positive. It's also seen as a strategic move to enhance AbbVie's long-term pipelines.
AbbVie's $8.7 Billion Bet on Cerevel Is Risky but Smart, Analysts SayAnalyst Mohit Bansal opines AbbVie might favour purchasing Cerevel due to its perceived clean IP and daily dosing for its principal schizophrenia medication. He anticipates potential benefit from peak adjustments in sales surpassing $3B.
1
ColumnsWeekly Insider Money Tracking: Directors of Cerevel Therapeutics Buy Close to $400 Million Worth of Stock
1 | Below is a look at the top insider trades with the biggest value in the past week.
Last week, the major shareholder of $Cerevel Therapeutics Holdings(CERE.US$, Bain Capital Investors Llc, purchased 5,480,052 shares worth $125 million in a transaction dated October 16th. The other two principal shareholders, Koppel Adam and Gordon Christopher, also bought an equivalent amount of stock at ...
Last week, the major shareholder of $Cerevel Therapeutics Holdings(CERE.US$, Bain Capital Investors Llc, purchased 5,480,052 shares worth $125 million in a transaction dated October 16th. The other two principal shareholders, Koppel Adam and Gordon Christopher, also bought an equivalent amount of stock at ...
15
2
ColumnsUS Top Gap Ups and Downs on 4/24: CS, PHG, BIDU, HTHT and More
Here are the top gap ups and downs for the stocks with a market cap above $5 billion after the previous market closed (gaps range from large to small):
Gap Ups
1. $Royal Philips(PHG.US$ - up 13.10%
2. $Wipro(WIT.US$ - up 2.0%
3. $Fresenius Medical Care(FMS.US$ - up 1.5%
4. $Credit Suisse(CS.US$ - up 1.1%
5. $Elbit Systems(ESLT.US$ - up 1.1%
6. $Cerevel Therapeutics Holdings(CERE.US$ - up 0.8%
7. $Aegon Ltd(AEG.US$ - up 0.7%
8. $TotalEnergies(TTE.US$ - up 0.4%...
Gap Ups
1. $Royal Philips(PHG.US$ - up 13.10%
2. $Wipro(WIT.US$ - up 2.0%
3. $Fresenius Medical Care(FMS.US$ - up 1.5%
4. $Credit Suisse(CS.US$ - up 1.1%
5. $Elbit Systems(ESLT.US$ - up 1.1%
6. $Cerevel Therapeutics Holdings(CERE.US$ - up 0.8%
7. $Aegon Ltd(AEG.US$ - up 0.7%
8. $TotalEnergies(TTE.US$ - up 0.4%...
+15
11
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg